Upon the establishment of a local and systemic inflammatory state in IBD, several inflammatory biomarkers, including C-reactive protein (CRP), serum amyloid A (SAA), TNF-α, interleukin IL-1β, IL-6, IL-8, IL-12, and calprotectin, increase significantly. This evidence concerns the gene TNF and irritable bowel syndrome.